Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
01/11/2022 01/12/2022 01/13/2022 01/14/2022 01/17/2022 Date
354.9(c) 355(c) 342.1(c) 332.8(c) 336.9(c) Last
728 607 997 991 967 955 744 417 641 068 Volume
+2.16% +0.03% -3.63% -2.72% +1.23% Change
More quotes
Estimated financial data (e)
Sales 2021 27 374 M 3 030 M 3 030 M
Net income 2021 3 004 M 332 M 332 M
Net Debt 2021 4 158 M 460 M 460 M
P/E ratio 2021 30,5x
Yield 2021 0,98%
Sales 2022 29 204 M 3 232 M 3 232 M
Net income 2022 3 313 M 367 M 367 M
Net Debt 2022 2 279 M 252 M 252 M
P/E ratio 2022 27,6x
Yield 2022 1,04%
Capitalization 91 761 M 10 185 M 10 157 M
EV / Sales 2021 3,50x
EV / Sales 2022 3,22x
Nbr of Employees 10 667
Free-Float -
More Financials
Company
Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business... 
More about the company
Ratings of Getinge AB
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about GETINGE AB
01/17Getinge appoints Patricia Fitch as President North America Region
AQ
01/17Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as P..
AQ
01/14GETINGE : Quadruplets safely delivered at the Regional Specialist Hospital in Wroclaw
PU
01/13GETINGE : program recognizes dedicated North American vessel harvesters
PU
01/10GETINGE ANNOUNCES ITS YEAR-END REPOR : 00 CET followed by a conference call at 10:00 CET
AQ
2021Getinge Buys US-based Talis Clinical For $66 Million
MT
2021Getinge acquires Talis Clinical LLC, a leading innovator of High Acuity cloud-based sof..
AQ
2021GETINGE AB (OM : GETI B) acquired Talis Clinical, LLC for approximately SEK 600 million.
CI
2021Getinge informs about FDA Letter to Healthcare Providers related to Intra-Aortic Balloo..
AQ
2021GETINGE AB(OM : GETI B) added to S&P EUROPE 350 - Health Care Equipment & Services (Indust..
CI
2021GETINGE AB(OM : GETI B) added to S&P International 700
CI
2021GETINGE AB(OM : GETI B) added to S&P EUROPE 350
CI
2021GETINGE AB(OM : GETI B) added to S&P EUROPE 350 - Health Care
CI
2021GETINGE AB(OM : GETI B) added to S&P Global 1200
CI
2021Getinge provides more information on FDA communication to health care providers
AQ
More news
News in other languages on GETINGE AB
2021GETINGE AB (OM : GETI B) a acquis Talis Clinical, LLC pour environ 600 millions de couronn..
2021Le fabricant de matériel médical Getinge relève ses objectifs, citant l'impact du COVID..
2021OPINIONES DE LOS ANALISTAS DEL DÍA : Prosegur, Puma, Schneider, Ipsen, SMCP, Temenos, UBS,..
2021íVae Victis !
2021Vae Victis !
More news
Analyst Recommendations on GETINGE AB
More recommendations
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 336,90 SEK
Average target price 416,30 SEK
Spread / Average Target 23,6%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-15.77%10 068
MASIMO CORPORATION-20.39%12 871
PENUMBRA, INC.-17.31%8 876
NOVOCURE LIMITED-7.94%7 176
SHOCKWAVE MEDICAL, INC.-6.36%5 895
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-8.20%5 522